Cardio-Oncology
Specificity of definition of ICI-related myocarditis improved after minor change
A modified version of the International Cardio-Oncology Society definition of immune checkpoint inhibitor-associated myocarditis may improve its predictive value, researchers reported.
Black patients may be at elevated cardiotoxicity, HF risk after chemotherapy
Results of a large meta-analysis indicated that Black race was associated with greater odds of cardiotoxicity and HF diagnosis after chemotherapy compared with white and non-Black race, a speaker reported.
HF, arrythmias more common after radiation-treated breast cancer vs. matched controls
In the 10 years after radiotherapy for breast cancer, the rate of CV mortality remained second to cancer mortality; however, patients had increased incidence of HF and arrhythmias compared with matched controls, researchers reported.
Haptoglobin gene expression linked to cardiomyopathy among childhood cancer survivors
Haptoglobin gene expression in the blood appeared associated with anthracycline-related cardiomyopathy among childhood cancer survivors, according to study results.
Optimizing CV health behaviors may lower risk for CVD and cancer
Improvement in the American Heart Association’s Life’s Simple 7 CV health score was associated with lower risk for cancer and CVD during nearly 25 years of follow-up, researchers reported.
Expert panel issues first pediatric cardio-oncology guidelines
An expert panel of pediatric cardiologists and oncologists issued its inaugural cardio-oncology guidelines for the management of pediatric patients receiving anticancer therapy.
General CVD risk prediction tools appear to be useful for cancer survivors
CVD risk prediction tools developed for a primary care population in New Zealand were similarly useful risk predictors for adult cancer survivors, researchers reported.
Close BP monitoring important before, during and after cancer therapy
In a scientific statement, the American Heart Association issued guidance on the epidemiology, diagnosis and management of cancer therapy-induced hypertension.
Exercise during chemotherapy improves cardiorespiratory fitness at 1 year
A physical exercise intervention delivered during chemotherapy was associated with a return to similar levels of baseline cardiorespiratory fitness at 1 year compared with exercise after chemotherapy, researchers reported.
Frailty status more predictive of TAVR outcomes than cancer status
Among patients undergoing transcatheter aortic valve replacement, increased frailty was independently associated with worse outcomes, including all-cause death, whereas cancer history did not independently affect frailty-adjusted mortality.